Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 2 institutions in 1 country.
Csenge Anna Felegyi-TóthDepartment of Pharmacognosy, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary.ORCID 0000-0001-6260-465X
Tímea HeilmannDepartment of Pharmacognosy, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary.
Eszter BudaDepartment of Pharmacognosy, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary.
Bence StipsiczInstitute of Biology, Doctoral School of Biology, Eötvös Loránd University, Pázmány Péter sétány 1/C, H-1117 Budapest, Hungary.
Alexandra SimonDepartment of Pharmacognosy, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary.ORCID 0000-0001-8189-4170
Imre BoldizsárDepartment of Pharmacognosy, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary.ORCID 0000-0001-7852-8364
Szilvia BőszeELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Eötvös Loránd University, Pázmány Péter sétány 1/A, H-1117 Budapest, Hungary.
Eszter RiethmüllerDepartment of Pharmacognosy, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary.
Ágnes AlbertiDepartment of Pharmacognosy, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary.ORCID 0000-0003-3096-4057
Semmelweis University · HUEötvös Loránd University · HU
Funding
National Research, Development and Innovation Office 2018-1.2.1-NKP-2018-00005National Research, Development and Innovation Office EFOP-1.8.0-VEKOP-17-2017-0000National Research, Development and Innovation Office FK 125302National Research, Development and Innovation Office K 120342National Research, Development and Innovation Office K 135712National Research, Development and Innovation Office K-142904National Research, Development and Innovation Office TKP2020-IKA-05National Research, Development and Innovation Office VEKOP-2.3.3-15-2017-00020
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Evaluation of the Chemical Stability, Membrane Permeability and Antiproliferative Activity of Cyclic Diarylheptanoids from European Hornbeam ( · full record | Socratic